Horáková, D <br/><br/>
Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study.  [electronic resource] 

 -  Folia biologica  2010 
 - 242-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0015-5500 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Adult<br/>Anti-Inflammatory Agents--therapeutic use<br/>Apolipoprotein E4--genetics<br/>Atrophy--pathology<br/>Azathioprine--therapeutic use<br/>Brain--pathology<br/>Disease Progression<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Humans<br/>Image Processing, Computer-Assisted<br/>Immunosuppressive Agents--therapeutic use<br/>Interferon beta-1a<br/>Interferon-beta--therapeutic use<br/>Longitudinal Studies<br/>Magnetic Resonance Imaging<br/>Male<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Nerve Fibers, Myelinated--pathology<br/>Prednisone--therapeutic use